[1]
Schlesinger, T., Kircik, L., Del Rosso, J., Rigel, D., Lebwohl, M., Berman, B., Armstrong, A., Bhatia, N., Patel, V.A., Narayanan, S., Koscielny, V. and Kasujee, I. 2023. Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 3 (May 2023), 771–787. DOI:https://doi.org/10.25251/skin.7.3.3.